NasdaqCM - Delayed Quote USD

Tenon Medical, Inc. (TNON)

1.1700
+0.0500
+(4.46%)
At close: 4:00:00 PM EDT
1.1407
-0.03
(-2.50%)
After hours: 6:11:34 PM EDT
Loading Chart for TNON
  • Previous Close 1.1200
  • Open 1.1100
  • Bid 0.8424 x 200
  • Ask 1.4400 x 200
  • Day's Range 1.1100 - 1.1899
  • 52 Week Range 0.9100 - 15.7880
  • Volume 196,326
  • Avg. Volume 7,349,519
  • Market Cap (intraday) 8.88M
  • Beta (5Y Monthly) 1.24
  • PE Ratio (TTM) --
  • EPS (TTM) -2.2500
  • Earnings Date Aug 11, 2025 - Aug 15, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 2.75

Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain. It also provides Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI Joint along its longitudinal axis. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.

www.tenonmed.com

27

Full Time Employees

December 31

Fiscal Year Ends

Recent News: TNON

View More

Performance Overview: TNON

Trailing total returns as of 5/20/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

TNON
37.77%
S&P 500 (^GSPC)
1.00%

1-Year Return

TNON
81.72%
S&P 500 (^GSPC)
11.91%

3-Year Return

TNON
99.67%
S&P 500 (^GSPC)
52.27%

5-Year Return

TNON
99.93%
S&P 500 (^GSPC)
99.91%

Compare To: TNON

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: TNON

View More

Valuation Measures

Annual
As of 5/19/2025
  • Market Cap

    8.50M

  • Enterprise Value

    2.30M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.69

  • Price/Book (mrq)

    1.51

  • Enterprise Value/Revenue

    0.70

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -81.35%

  • Return on Equity (ttm)

    -210.97%

  • Revenue (ttm)

    3.28M

  • Net Income Avi to Common (ttm)

    -13.71M

  • Diluted EPS (ttm)

    -2.2500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    10.31M

  • Total Debt/Equity (mrq)

    3.84%

  • Levered Free Cash Flow (ttm)

    -4.55M

Research Analysis: TNON

View More

Company Insights: TNON

Research Reports: TNON

View More

People Also Watch